These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20705253)

  • 1. Efficacy of modafinil in 10 Taiwanese patients with narcolepsy: findings using the Multiple Sleep Latency Test and Epworth Sleepiness Scale.
    Yeh SB; Schenck CH
    Kaohsiung J Med Sci; 2010 Aug; 26(8):422-7. PubMed ID: 20705253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group.
    Ann Neurol; 1998 Jan; 43(1):88-97. PubMed ID: 9450772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy.
    Lavault S; Dauvilliers Y; Drouot X; Leu-Semenescu S; Golmard JL; Lecendreux M; Franco P; Arnulf I
    Sleep Med; 2011 Jun; 12(6):550-6. PubMed ID: 21576035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate.
    Huang YS; Guilleminault C
    Pediatr Neurol; 2009 Jul; 41(1):9-16. PubMed ID: 19520267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
    Black J; Pardi D; Hornfeldt CS; Inhaber N
    Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.
    Högl B; Saletu M; Brandauer E; Glatzl S; Frauscher B; Seppi K; Ulmer H; Wenning G; Poewe W
    Sleep; 2002 Dec; 25(8):905-9. PubMed ID: 12489899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy.
    Saletu M; Anderer P; Semlitsch HV; Saletu-Zyhlarz GM; Mandl M; Zeitlhofer J; Saletu B
    Psychiatry Res; 2007 Jan; 154(1):69-84. PubMed ID: 17187965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference in the characteristics of subjective and objective sleepiness between narcolepsy and essential hypersomnia.
    Komada Y; Inoue Y; Mukai J; Shirakawa S; Takahashi K; Honda Y
    Psychiatry Clin Neurosci; 2005 Apr; 59(2):194-9. PubMed ID: 15823167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
    Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial.
    Orlikowski D; Chevret S; Quera-Salva MA; Laforêt P; Lofaso F; Verschueren A; Pouget J; Eymard B; Annane D
    Clin Ther; 2009 Aug; 31(8):1765-73. PubMed ID: 19808135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy.
    Aldrich MS; Chervin RD; Malow BA
    Sleep; 1997 Aug; 20(8):620-9. PubMed ID: 9351129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.
    Harsh JR; Hayduk R; Rosenberg R; Wesnes KA; Walsh JK; Arora S; Niebler GE; Roth T
    Curr Med Res Opin; 2006 Apr; 22(4):761-74. PubMed ID: 16684437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
    Black J; Houghton WC
    Sleep; 2006 Jul; 29(7):939-46. PubMed ID: 16895262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
    Black J; Swick T; Bogan R; Lai C; Carter LP
    Sleep Med; 2016 Aug; 24():57-62. PubMed ID: 27810187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of modafinil in the treatment of narcolepsy: a long term follow-up study.
    Besset A; Chetrit M; Carlander B; Billiard M
    Neurophysiol Clin; 1996; 26(1):60-6. PubMed ID: 8657099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatigue in systemic lupus erythematosus: contributions of disordered sleep, sleepiness, and depression.
    Iaboni A; Ibanez D; Gladman DD; Urowitz MB; Moldofsky H
    J Rheumatol; 2006 Dec; 33(12):2453-7. PubMed ID: 17143980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group.
    Neurology; 2000 Mar; 54(5):1166-75. PubMed ID: 10720292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Italian version of the Epworth sleepiness scale: external validity.
    Vignatelli L; Plazzi G; Barbato A; Ferini-Strambi L; Manni R; Pompei F; D'Alessandro R;
    Neurol Sci; 2003 Feb; 23(6):295-300. PubMed ID: 12624716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modafinil improves information processing speed and increases energetic resources for orientation of attention in narcoleptics: double-blind, placebo-controlled ERP studies with low-resolution brain electromagnetic tomography (LORETA).
    Saletu M; Anderer P; Saletu-Zyhlarz GM; Mandl M; Saletu B; Zeitlhofer J
    Sleep Med; 2009 Sep; 10(8):850-8. PubMed ID: 19342295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EEG-mapping differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil.
    Saletu MT; Anderer P; Saletu-Zyhlarz GM; Mandl M; Arnold O; Nosiska D; Zeitlhofer J; Saletu B
    Eur Arch Psychiatry Clin Neurosci; 2005 Feb; 255(1):20-32. PubMed ID: 15538594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.